By Mill Chart
Last update: May 19, 2025
RESMED INC (NYSE:RMD) stands out as a compelling candidate for quality investors, meeting stringent criteria for profitability, growth, and financial health. The company, a leader in digital health and cloud-connected medical devices, demonstrates consistent revenue and earnings growth, high returns on capital, and a strong balance sheet.
While RMD trades at a premium with a P/E of 27.7, its strong earnings growth (14.5% expected annually) and high profitability justify the valuation. Analysts project continued revenue growth of 8.4% over the next three years, supported by demand for respiratory and sleep disorder solutions.
Our Caviar Cruise screener lists more quality stocks updated daily. For a deeper analysis, review the full fundamental report on RMD.
This is not investing advice. Always conduct your own research before making investment decisions.
253.68
+2.8 (+1.12%)
Find more stocks in the Stock Screener
RESMED INC (NYSE:RMD) is a high-quality stock with strong profitability, low debt, and consistent growth, making it a candidate for long-term investors.